NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00000675

Locations: 🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States
🇺🇸
Univ of Washington, Seattle, Washington, United States

Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component

Not Applicable

Completed

Conditions: Cytomegalovirus Retinitis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 240

Registration Number: NCT00000665

Locations: 🇺🇸
UCLA - Jules Stein Eye Institute / SOCA, Los Angeles, California, United States
🇺🇸
Northwestern Univ / SOCA, Chicago, Illinois, United States
🇺🇸
UCSD - Shiley Eye Ctr / SOCA, La Jolla, California, United States

and more 6 locations

A Study of Patients With AIDS Syndrome

Completed

Conditions: Lymphoma, Non-Hodgkin
HIV Infections
Sarcoma, Kaposi
Lymphoma, AIDS-Related

First Posted Date: 2001-08-31

Last Posted Date: 2008-09-12

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 5000

Registration Number: NCT00001120

Locations: 🇺🇸
Univ of Hawaii, Honolulu, Hawaii, United States
🇺🇸
Willow Clinic, Menlo Park, California, United States
🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States

and more 20 locations

A Blood Test to Look at Cells of the Immune System in Healthy Children

Completed

Conditions: HIV Infections
HIV Seronegativity

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 630

Registration Number: NCT00001109

Locations: 🇺🇸
North Broward Hosp District, Fort Lauderdale, Florida, United States
🇺🇸
Children's Hosp at Albany Med Ctr, Albany, New York, United States
🇺🇸
Cedars Sinai / UCLA Med Ctr, Los Angeles, California, United States

and more 42 locations

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Phase 3

Withdrawn

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2015-05-18

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00011128

Locations: 🇺🇸
Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States

and more 27 locations

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Not Applicable

Completed

Conditions: Tuberculosis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00000950

Locations: 🇺🇸
Emory Univ, Atlanta, Georgia, United States
🇺🇸
Beth Israel Med Ctr, New York, New York, United States
🇺🇸
Queens Med Ctr, Honolulu, Hawaii, United States

and more 10 locations

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

Phase 2

Completed

Conditions: HIV Infections
Mycobacterium Avium-intracellulare Infection

First Posted Date: 2001-08-31

Last Posted Date: 2011-02-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 100

Registration Number: NCT00000644

Locations: 🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States

A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients

Phase 2

Completed

Conditions: Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 300

Registration Number: NCT00000655

Locations: 🇺🇸
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
🇺🇸
Univ of Cincinnati, Cincinnati, Ohio, United States
🇺🇸
Veterans Administration Med Ctr, Washington, District of Columbia, United States

and more 35 locations

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2012-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 92

Registration Number: NCT00013663

Locations: 🇺🇸
New York Hosp - Cornell Med Ctr, New York, New York, United States

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Completed

Conditions: HIV Infections
Hepatitis C

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 44

Registration Number: NCT00006643

Locations: 🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Univ of Hawaii, Honolulu, Hawaii, United States
🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy